JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients

NCT01269996 Phase 4 COMPLETED

To evaluate the efficacy and safety of a new treatment regimen of metformin plus sitagliptin (Janumet) followed by a long-acting basal insulin (Lantus) treatment compared to the usual treatment regimen of metformin followed by sulfonylurea and intermediate-acting basal insulin in Type 2 Diabetes Mellitus patients.

Details

Lead sponsor	Chinese University of Hong Kong
Phase	Phase 4
Status	COMPLETED
Enrolment	71
Start date	2011-05
Completion	2015-02

Conditions

• Type 2 Diabetes Mellitus

Interventions

• Janumet, Lantus
• metformin, gliclazide, protaphane

Primary outcomes

• To evaluate the treatment efficacy — one year
  The change in HbA1c in 1 year compare to baseline.

Countries

Hong Kong